• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

To Bridge, Blossom, or Boost: That Is the Question.

作者信息

Arend Sandra M, Jedema Inge

机构信息

Department of Infectious Diseases, Leiden University Medical Center, The Netherlands.

Department of Hematology, Leiden University Medical Center, The Netherlands.

出版信息

Clin Infect Dis. 2020 Mar 17;70(7):1438-1441. doi: 10.1093/cid/ciz370.

DOI:10.1093/cid/ciz370
PMID:31067571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7076747/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/7076747/b70100f133d6/ciz370f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/7076747/b70100f133d6/ciz370f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/7076747/b70100f133d6/ciz370f0001.jpg

相似文献

1
To Bridge, Blossom, or Boost: That Is the Question.搭建、绽放还是提升：这就是问题所在。
Clin Infect Dis. 2020 Mar 17;70(7):1438-1441. doi: 10.1093/cid/ciz370.
2
Failure of Cytomegalovirus-Specific CD8+ T Cell Levels at Viral DNAemia Onset to Predict the Eventual Need for Preemptive Antiviral Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
J Infect Dis. 2019 Apr 16;219(9):1510-1512. doi: 10.1093/infdis/jiy746.
3
An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后巨细胞病毒感染的治疗进展。
Expert Rev Hematol. 2019 Nov;12(11):937-945. doi: 10.1080/17474086.2019.1657399. Epub 2019 Aug 25.
4
Cytomegalovirus antiviral drug resistance: future prospects for prevention, detection and management.巨细胞病毒抗病毒药物耐药性：预防、检测与管理的未来前景
Future Microbiol. 2015;10(10):1545-8. doi: 10.2217/fmb.15.82. Epub 2015 Oct 6.
5
Cytomegalovirus in hematopoietic stem cell transplant recipients.造血干细胞移植受者中的巨细胞病毒。
Infect Dis Clin North Am. 2010 Jun;24(2):319-37. doi: 10.1016/j.idc.2010.01.008.
6
Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic cell transplantation.异基因造血细胞移植中巨细胞病毒的治疗策略
Immunotherapy. 2015;7(10):1059-71. doi: 10.2217/imt.15.70. Epub 2015 Oct 28.
7
Combination therapy for multidrug-resistant cytomegalovirus disease.耐多药巨细胞病毒病的联合治疗
Transpl Infect Dis. 2015 Oct;17(5):751-5. doi: 10.1111/tid.12435. Epub 2015 Oct 3.
8
Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.通过过继性T细胞疗法增强造血干细胞移植后的病毒特异性免疫。
Hum Immunol. 2004 May;65(5):550-7. doi: 10.1016/j.humimm.2004.02.016.
9
Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.采用病毒特异性T细胞系对异基因干细胞移植后的早期巨细胞病毒感染进行过继性细胞治疗。
Lancet. 2003 Oct 25;362(9393):1375-7. doi: 10.1016/S0140-6736(03)14634-X.
10
Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy.造血干细胞移植后巨细胞病毒感染：现状与未来免疫治疗。
Int J Mol Sci. 2019 May 30;20(11):2666. doi: 10.3390/ijms20112666.

本文引用的文献

1
First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)-specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell Transplantation.供体源性人巨细胞病毒（HCMV）特异性 T 细胞的一线治疗可通过促进异基因干细胞移植后抗病毒免疫来减少持续性 HCMV 感染。
Clin Infect Dis. 2020 Mar 17;70(7):1429-1437. doi: 10.1093/cid/ciz368.
2
Cytomegalovirus Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patient.造血干细胞移植受者和血液系统恶性肿瘤患者的巨细胞病毒感染。
Infect Dis Clin North Am. 2019 Jun;33(2):485-500. doi: 10.1016/j.idc.2019.02.008. Epub 2019 Mar 30.
3
The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients.
巨细胞病毒 ELISPOT 检测在预测造血细胞移植受者低水平 CMV 再激活结局中的作用。
J Infect Dis. 2019 Feb 23;219(6):898-907. doi: 10.1093/infdis/jiy592.
4
CMV seronegative donors: Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity.巨细胞病毒血清学阴性供体：对巨细胞病毒感染临床严重程度及巨细胞病毒特异性免疫重建的影响。
Transpl Immunol. 2018 Aug;49:54-58. doi: 10.1016/j.trim.2018.04.003. Epub 2018 Apr 18.
5
Control of Cytomegalovirus Viremia after Allogeneic Stem Cell Transplantation: A Review on CMV-Specific T Cell Reconstitution.异基因造血干细胞移植后巨细胞病毒血症的控制：对 CMV 特异性 T 细胞重建的综述。
Biol Blood Marrow Transplant. 2018 Sep;24(9):1776-1782. doi: 10.1016/j.bbmt.2018.03.028. Epub 2018 Apr 4.
6
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.来特莫韦预防造血干细胞移植后巨细胞病毒感染。
N Engl J Med. 2017 Dec 21;377(25):2433-2444. doi: 10.1056/NEJMoa1706640. Epub 2017 Dec 6.
7
Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation.造血干细胞移植后巨细胞病毒感染的新观念
Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):233-238. doi: 10.1016/j.hemonc.2017.05.001. Epub 2017 Jun 14.
8
Immunotherapy for transplantation-associated viral infections.移植相关病毒感染的免疫疗法。
J Clin Invest. 2017 Jun 30;127(7):2513-2522. doi: 10.1172/JCI90599. Epub 2017 Jun 19.
9
Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation.使用 Quantiferon-CMV 检测异基因造血干细胞移植后巨细胞病毒并发症。
J Infect Dis. 2017 Jun 1;215(11):1684-1694. doi: 10.1093/infdis/jix192.
10
Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后 CMV 感染的治疗。
Expert Rev Hematol. 2016 Jun;9(6):585-96. doi: 10.1080/17474086.2016.1174571. Epub 2016 Apr 18.